Atara Biotherapeutics
ATRA
ATRA
140 hedge funds and large institutions have $1.61B invested in Atara Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 145 → 140 (-5)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
140
Holding in Top 10
2
Calls
$677K
Puts
$401K
Top Buyers
| 1 | +$54.5M | |
| 2 | +$28.3M | |
| 3 | +$19.8M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$9.29M |
| 5 |
JPMorgan Chase & Co
New York
|
+$8.97M |
Top Sellers
| 1 | -$11M | |
| 2 | -$10.6M | |
| 3 | -$7.69M | |
| 4 |
BM
Bridger Management
New York
|
-$7.13M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$6.62M |